Examine This Report on Lodelcizumab for preclinical development
RescoredLikely AI
Junshi Biosciences was the very first Chinese pharmaceutical firm that received advertising and marketing acceptance for anti-PD-1 monoclonal antibody in China. Its very first-in-human anti-BTLA monoclonal...
The Verdict
ClassificationLikely AI
ConfidenceHigh confidence
Analyzedtext, image
ImageLikely AI
Community Verdict
Sign in to vote
Be the first to vote on this assessment.
Embed Badge
Add this badge to your site to show the AI classification for this content.
[](https://real.press/content/de6d5ddb-6c93-4731-bc29-3daf4e258aef)